Paul Andrew Moore

Chief Scientific Officer, Zymeworks Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.7M

Companies

Latest trade

Jan 12, 2026

Companies

Zymeworks Inc.Chief Scientific Officer −$0.7M

Trades

ZYME Sold 9,560 shares at $22.67 $0.2M Jan 12

ZYME Sold 20,110 shares at $25.10 $0.5M Jan 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.